Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Luoyang Zhengmu Biotechnology is a China-based veterinary pharmaceutical manufacturer focused on animal-health active pharmaceutical ingredients and related veterinary drug products. The company is GMP-certified for veterinary drug manufacturing and markets a portfolio centered on sulfonamides, quinolones, and related anti-infective compounds used in livestock and other veterinary applications. Public company-profile and registry information indicate that it manufactures and sells products such as sulfadimidine, sulfadiazine, norfloxacin derivatives, pefloxacin mesilate, diaveridine, and enrofloxacin APIs, and also engages in veterinary drug R&D, technical services, and import/export activities. The business appears to operate primarily as a commercial producer rather than a clinical-stage biotech developer, with manufacturing operations in Luoyang, Henan, and export-facing commercial activity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Luoyang Zhengmu Biotechnology.